調查批次:CHT2017-04 | 檢體寄出日期:2017-09-25 | 報告回收截止日期:2017-10-02 | 回收份數:22 |
T3 檢驗院際品管調查結果: | ||
2.歷次品管檢體 T3 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 1 |
2 |
5 |
232 |
-8 |
-3.3 |
-0.4 |
0.1 |
-14 |
168 |
-1 |
-0.6 |
-0.1 |
1.2 |
-2 |
RH07b | RH07 | 4 |
2 |
3 |
234 |
-6 |
-2.5 |
-0.3 |
0.3 |
-10 |
132 |
-37 |
-21.9 |
-2.7 |
-1.0 |
-91 |
RH14 | RH14 | 4 |
2 |
3 |
241 |
1 |
0.4 |
0.1 |
0.9 |
2 |
148 |
-21 |
-12.4 |
-1.6 |
0.0 |
-52 |
RH15 | RH15 | 4 |
2 |
5 |
224 |
-16 |
-6.7 |
-0.8 |
-0.6 |
-28 |
158 |
-11 |
-6.5 |
-0.8 |
0.6 |
-27 |
CL009 | CL009 | 4 |
2 |
5 |
225 |
-15 |
-6.3 |
-0.8 |
-0.5 |
-26 |
156 |
-13 |
-7.7 |
-1.0 |
0.5 |
-32 |
CL010 | CL010 | 4 |
2 |
5 |
218 |
-22 |
-9.2 |
-1.1 |
-1.1 |
-38 |
25 |
-144 |
-85.2 |
-10.7 |
-7.4 |
-355 |
CL012 | CL012 | 7 |
2 |
3 |
254 |
14 |
5.8 |
0.7 |
2.0 |
24 |
143 |
-26 |
-15.4 |
-1.9 |
-0.3 |
-64 |
CL014a | CL014 | 4 |
2 |
3 |
223 |
-17 |
-7.1 |
-0.9 |
-0.7 |
-30 |
154 |
-15 |
-8.9 |
-1.1 |
0.4 |
-37 |
Median of RIA Group |
229 |
151 |
||||||||||||||
Range of RIA Group |
218 - 254 |
25 - 168 |
||||||||||||||
Robust mean of RIA Group |
231 ( n = 8 ) |
148 ( n = 8 ) |
||||||||||||||
Robust SD of RIA Group |
11.4 |
16.7 |
||||||||||||||
CV of RIA Group |
4.9% |
11.3% |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 7 |
4 |
9 |
238 |
-2 |
-0.8 |
-0.1 |
-0.3 |
-3 |
149 |
-20 |
-11.8 |
-1.5 |
-1.4 |
-49 |
RH02c | RH02 | 3 |
4 |
1 |
272 |
32 |
13.3 |
1.7 |
1.0 |
56 |
194 |
25 |
14.8 |
1.8 |
1.1 |
62 |
RH06 | RH06 | 7 |
4 |
9 |
223 |
-17 |
-7.1 |
-0.9 |
-0.9 |
-30 |
158 |
-11 |
-6.5 |
-0.8 |
-0.9 |
-27 |
RH07a | RH07 | 7 |
4 |
2 |
220 |
-20 |
-8.3 |
-1.0 |
-1.0 |
-35 |
166 |
-3 |
-1.8 |
-0.2 |
-0.4 |
-7 |
RH12 | RH12 | 3 |
4 |
2 |
225 |
-15 |
-6.3 |
-0.8 |
-0.8 |
-26 |
168 |
-1 |
-0.6 |
-0.1 |
-0.3 |
-2 |
RH15b | RH15b | 4 |
4 |
13 |
267 |
27 |
11.3 |
1.4 |
0.8 |
47 |
197 |
28 |
16.6 |
2.1 |
1.3 |
69 |
RH19 | RH19 | 7 |
4 |
2 |
226 |
-14 |
-5.8 |
-0.7 |
-0.8 |
-24 |
155 |
-14 |
-8.3 |
-1.0 |
-1.0 |
-35 |
RH20 | RH20 | 8 |
4 |
7 |
297 |
57 |
23.8 |
3.0 |
1.9 |
99 |
189 |
20 |
11.8 |
1.5 |
0.8 |
49 |
CL005 | CL005 | 7 |
4 |
9 |
231 |
-9 |
-3.8 |
-0.5 |
-0.6 |
-16 |
157 |
-12 |
-7.1 |
-0.9 |
-0.9 |
-30 |
CL006a | CL006 | 4 |
4 |
1 |
251 |
11 |
4.6 |
0.6 |
0.2 |
19 |
179 |
10 |
5.9 |
0.7 |
0.3 |
25 |
CL008 | CL008 | 7 |
4 |
2 |
230 |
-10 |
-4.2 |
-0.5 |
-0.7 |
-17 |
164 |
-5 |
-3.0 |
-0.4 |
-0.5 |
-12 |
CL011 | CL011 | 0 |
4 |
13 |
259 |
19 |
7.9 |
1.0 |
0.5 |
33 |
181 |
12 |
7.1 |
0.9 |
0.4 |
30 |
CL013b | CL013b | 2 |
4 |
1 |
249 |
9 |
3.8 |
0.5 |
0.1 |
16 |
184 |
15 |
8.9 |
1.1 |
0.5 |
37 |
CL015b | CL015b | 3 |
4 |
7 |
283 |
43 |
17.9 |
2.2 |
1.4 |
75 |
193 |
24 |
14.2 |
1.8 |
1.0 |
59 |
Median of CLIA Group |
244 |
174 |
||||||||||||||
Range of CLIA Group |
220 - 297 |
149 - 197 |
||||||||||||||
Robust mean of CLIA Group |
247 ( n = 14 ) |
174 ( n = 14 ) |
||||||||||||||
Robust SD of CLIA Group |
26.1 |
18.4 |
||||||||||||||
CV of CLIA Group |
10.6% |
10.6% |
||||||||||||||
Median of All Labs |
233 |
161 |
||||||||||||||
Range of All Labs |
218 - 297 |
25 - 197 |
||||||||||||||
Robust mean of All Labs |
240 ( n = 22 ) |
165 ( n = 22 ) |
||||||||||||||
Robust SD of All Labs |
20.9 |
21.7 |
||||||||||||||
CV of All Labs |
8.7% |
13.2%
|
||||||||||||||
Certified assigned value ( Xa )( ng/dL ) |
240 |
169 |
||||||||||||||
Expanded uncertainty ( Ua ) |
2.41 |
1.69 |
||||||||||||||
Relative expanded uncertainty |
1.0% |
1.0% |
||||||||||||||
Coverage factor k |
2.6 |
2.6 |
||||||||||||||
Effective degrees of freedom veff |
5 |
5 |
||||||||||||||
SD for proficiency assessment ( σp ) |
19.20 |
13.52 |
||||||||||||||
Adjusted SD for proficiency assessment ( σp ' ) |
- |
- |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH15b, RH19, RH20, CL005, CL006a, CL008, CL011, CL013b, CL015b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL006a, CL013b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL014a, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, |
Siemens ADVIA Centaur |
7 |
RH20, CL015b, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
RH15b, CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 臺北信維郵局第 624 信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2017-10-05